While non-steroidal MRAs have not yet been investigated in type 1 diabetes, based on their observed benefits in type 2 diabetes and their mechanism of action, similar kidney-protective effects are anticipated, emphasising the need for dedicated studies with finerenone in people with type 1 diabetes and CKD, including their use in combination with other repurposed therapies such as SGLT2i and GLP1-RAs
Rather than copying the peptide structure of the natural GLP-1 hormone, it uses a chemically engineered small molecule capable of activating the same receptor
However, you should not stop taking Trazodone without first discussing it with your AgelessRx prescriber
Injection site reactions including temporary redness, swelling, or itching occur occasionally
Knowing how long semaglutide takes to work helps set expectations for when these initial adjustments resolve
Rotating injection sites and using a 29- to 31-gauge needle cuts the incidence